companyprofile
Actions
Naba Alsaha Medical Services Co.
- Main Market
- Health Care Equipment & Svc
Stats Overview
-
Prev. Close -
-
Open N/A
-
High
-
Low
-
No. of Trades
-
Avg. Trade size* N/A
-
Volume Traded
-
Value Traded (^)
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Last Trade
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select a Maximum of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 20/03/2025 | 23/03/2025 | 10/04/2025 | Account Transfer | ^0.30 |
| 29/03/2023 | 22/06/2023 | 10/07/2023 | Account Transfer | ^0.30 |
CompanyProfilev2Financials
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Quarterly
| Balance Sheet | 2024-12-31 | 2023-12-31 | ||
|---|---|---|---|---|
| Total Assets |
324,406
|
276,718
|
- | - |
| Total Liabilities |
124,744
|
96,624
|
- | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
199,662
|
180,094
|
- | - |
| Total Liabilities and Shareholders Equity |
324,406
|
276,718
|
- | - |
| Statement of Income | 2024-12-31 | 2023-12-31 | ||
| Total Revenue (Sales/Operating) |
194,282
|
182,352
|
- | - |
| Net Profit (Loss) before Zakat and Tax |
25,058
|
54,862
|
- | - |
| Zakat and Income Tax |
-3,274
|
-2,480
|
- | - |
| Net Profit (Loss) after Zakat and Tax |
21,784
|
52,382
|
- | - |
| Total Comprehensive Income |
19,567
|
52,177
|
- | - |
| Profit (Loss) per Share |
2.07
|
4.99
|
- | - |
| Cash Flows | 2024-12-31 | 2023-12-31 | ||
| Net Cash From Operating Activities |
35,636
|
29,358
|
- | - |
| Net Cash From Investing Activities |
-38,810
|
-60,614
|
- | - |
| Net Cash From Financing Activities |
40,209
|
23,175
|
- | - |
| Cash and Cash Equivalents, Beginning of the Period |
5,746
|
13,826
|
- | - |
| Cash and Cash Equivalents, End of the Period |
42,781
|
5,745
|
- | - |
| All Figures in | Thousands | Thousands | ||
| All Currency In | ^ | ^ | ||
| Last Update Date | 2025-03-26 | 2024-04-16 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | ||||
|---|---|---|---|---|
| Total Assets | ||||
| Total Liabilities | ||||
| Total Shareholders Equity (After Deducting the Minority Equity) | ||||
| Total Liabilities and Shareholders Equity | ||||
| Statement of Income | ||||
| Total Revenue (Sales/Operating) | ||||
| Net Profit (Loss) before Zakat and Tax | ||||
| Zakat and Income Tax | ||||
| Net Profit (Loss) after Zakat and Tax | ||||
| Total Comprehensive Income | ||||
| Profit (Loss) per Share | ||||
| Cash Flows | ||||
| Net Cash From Operating Activities | ||||
| Net Cash From Investing Activities | ||||
| Net Cash From Financing Activities | ||||
| Cash and Cash Equivalents, Beginning of the Period | ||||
| Cash and Cash Equivalents, End of the Period | ||||
| All Figures in | ||||
| All Currency In | ||||
| Last Update Date |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
Medical operation of medical complexes and one day surgery centers The company current activity is the operation and management of Al Zahraa Hospital Manarat Al Haramain Pharmacy, Nabea Al Saha branch for the practice of maintenance work and the operation of buildings
Company History
Nabaa Al Saha Medical Services Company was established on 02.25.1405 AH On 04.24.1439 The partner decision was issued to change the company name to Nabaa Al Saha Medical Services Company and the company headquarters was also changed to be in the city of Al Khobar Pursuant to Ministerial Resolution No S.122 on 23.05.1440 AH corresponding to January 29.2019 AD The company was converted from a limited liability company to a closed joint stock company while retaining the commercial registration number and date with the same capital of twenty five million Saudi riyals
Company Bylaws
Equity Profile
- Authorized Capital (^) 105,000,000
- Issued Shares 10,500,000
- Paid Capital (^) 105,000,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2023-11-20
Investment limits
Risks of difficulty in recruiting health practitioners and highly qualified administrative cadres Inability to renew or amend existing contracts Risks related to the level of service quality Risks of concentrating the company revenues with revenues from the governmental and semi-governmental sectors Risks related to accounts receivable
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Ahmed youssef Mohamed abdel hak
Company Address:
Qatif 31911 KSA P.O. Box 887
Contact Details:
Telephone:
966138555000+
Fax
: 966138555000+
Email
: ahmed.youssef@alzahragh.com
Company Website:
| Name Of Subsidiary | Percentage Of Property | Main Business | Location Of Operation | Country Of Operation |
|---|---|---|---|---|
| Nabaa Al-Saha Architectural Contracting Company | 100.00% | General Contracting | Al Khoubar | KSA |
| Al Zahraa general hospital | 100.00% | Hospitals | Qatif | KSA |
| Manarat Al Haramain Pharmacy | 100.00% | pharmacies | Qatif | KSA |
| Nabaa Al-Saha Medical Services Company | 100.00% | maintenance and operation | Qatif | KSA |
| Al Anwar Medical Company | 100.00% | Hospitals | Hail | KSA |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
- ${title}${badge}